← Open Payments lookup

CHINYERE NZEKWE: Open Payments

NPI 1487235172 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,135 in 57 payments from 12 companies in 2025. Trend: 2023 $263 · 2024 $707 · 2025 $2,135

Food & beverage: $2,135
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$518
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$295
Neurocrine BioSciences, Inc.2$254
ABBVIE INC.10$226
Supernus Pharmaceuticals, Inc.8$222
E.R. Squibb & Sons, L.L.C.3$222
Alkermes, Inc.5$172
Lundbeck LLC4$78
Janssen Scientific Affairs, LLC1$58
Axsome Therapeutics, Inc.2$43

Products named: REXULTI, CAPLYTA, INGREZZA, VRAYLAR, Qelbree, COBENFY, ARISTADA, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.